Genetic-testing lab 23andMe plans to cut its workforce by 40% and end its therapeutics program in an effort to cut costs, the ...

DNA-testing company 23andMe Holding Co. will slash its workforce by about 40% and discontinue its therapeutics program as ...

The therapeutic programs of 23andMe include an antibody that restores the ability of the immune system to kill cancer cells.

DNA-testing company 23andMe said on Monday that it was firing roughly 40% of its workforce, more than 200 people, as Chief ...

Genetic testing firm 23andMe said on Monday it is reducing about 40%, or 200 employees, from its workforce and discontinuing ...

Me's big push into drug development, announced with great fanfare almost a decade ago, has ended with a whimper and sweeping ...

The struggling genetic testing company 23andMe says it will cut 40% of its workforce, or 200 jobs, as it fights for survival.

23andMe is shutting down its therapeutics development division, and plans to seek out buyers to find a new home for its ...

Me is closing its therapeutics division and will wind down ongoing clinical trials, the struggling genetic testing company ...

23andMe, a leading name in the genetic testing business, has revealed plans to lay off some 200 employees, or nearly 40% of ...

Another Bay Area company has announced significant job cuts ahead of the holidays. Genetic testing firm 23andMe announced on ...

Requesting deletion closes your account permanently and prevents your data from being used in further research (existing ...